Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amyloid and the gut

L B Lovat1, M B Pepys, P N Hawkins

  • 1Immunological Medicine Unit, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.

Digestive Diseases (Basel, Switzerland)
|May 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

T staging esophageal tumors with x rays.

Optica·2024
Same author

Bariatric and Metabolic Endoscopy: A New Paradigm.

Clinical and translational gastroenterology·2021
Same author

Protecting healthcare workers: A critical part of the COVID-19 response.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2021
Same author

Minichromosomal Maintenance Component Complex 5 (MCM5) as a Marker of Barrett's Esophagus-Related Neoplasia: A Feasibility Study.

Digestive diseases and sciences·2019
Same author

Spinal Stenosis in Familial Transthyretin Amyloidosis.

Journal of neuromuscular diseases·2019
Same author

Rare coding variant analysis in a large cohort of Ashkenazi Jewish families with inflammatory bowel disease.

Human genetics·2018
Same journal

Pancreatitis in Familial Dysautonomia Patients.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Treatment outcomes with empirical Clarithromycin-based triple therapy for Helicobacter pylori in Zambia, sub-Saharan Africa.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Endoscopic submucosal dissection-associated bacteremia: proper antibiotic management.

Digestive diseases (Basel, Switzerland)·2026
Same journal

The investigation and treatment of Helicobacter pylori for the prevention of gastric cancer: A narrative review and assessment of management approaches.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Analysis of Helicobacter pylori resistance and its trends in Chongqing: A 10-year retrospective study.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Early-onset colorectal cancer in Australia: environmental, microbial, and policy implications.

Digestive diseases (Basel, Switzerland)·2026
See all related articles

Systemic amyloidoses, caused by abnormal protein deposits, often affect the gut. Early diagnosis via gastrointestinal biopsies and targeted therapies significantly improve patient prognosis and outcomes.

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Pathology

Background:

  • Systemic amyloidoses are severe, life-threatening conditions.
  • Abnormal protein fibril deposition characterizes these disorders.
  • Gastrointestinal (GI) tract involvement is frequent in systemic amyloidoses.

Purpose of the Study:

  • To review the clinical features, diagnosis, and management of gastrointestinal involvement in systemic amyloidoses.
  • To highlight the diagnostic utility of GI biopsies and novel imaging techniques.
  • To discuss therapeutic strategies for improving patient prognosis.

Main Methods:

  • Review of clinical presentations, diagnostic modalities, and treatment options for GI amyloidosis.
  • Emphasis on endoscopic and radiological findings.

Related Experiment Videos

  • Discussion of scintigraphy using serum amyloid P component for disease quantification.

    • Main Results:

    • Gastrointestinal biopsies are diagnostic in 80% of patients with systemic amyloidosis.
    • Amyloid deposition can mimic various GI pathologies, including pseudo-tumors and hemorrhage.
    • Scintigraphy effectively visualizes and quantifies systemic amyloid deposits.
    • Nonspecific mucosal abnormalities are common findings on imaging and endoscopy.

    Conclusions:

    • Systemic amyloidoses require prompt diagnosis and management, with GI biopsies being highly effective.
    • Therapeutic strategies focusing on reducing precursor protein supply can improve outcomes.
    • Adjunctive treatments like nutritional support and motility-enhancing drugs are crucial for managing GI complications.